An open label, proof of concept study to assess the safety, PK and explore efficacy of a new compound in patients with active mild-to-moderate Ulcerative Colitis (UC).
Study
After 5 months of active recruiting the 7 trial sites had not enrolled enough patients. A fundamental challenge of recruiting patients for any UC study is the low prevalence of UC indication and the random nature of flareups. It takes an experienced recruiting provider to know how to target and engage prospective UC patients. For this particular study, a further complication was other available competitive studies which confused patients. Several vaccine requirements and complicated Inclusion/Exclusion criteria excluded large percentages of referred patients.
Strategy
nRollmed’s strategy was to target potential patients located in relative proximity to the trial sites, focusing specifically on potential patients and their care givers (parents, family members) who were suffering from Mild-to-Moderate UC. A very professional and accurate campaign was implemented to attract the relevant patients while full attention was given to the site’s enrollment efforts to provide maximum support and keep attention on this study among competing trials.
Results
50%
of all patients recruited
3
months to reach recruitment goals
nRollmed provided 50% of patients in 3 months
To discuss your study needs and how we can help recruit patients faster
